img

Global Swine Fever Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Swine Fever Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Swine fever, also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
Swine Fever Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Swine Fever Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Government Tender and Market Sales are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Swine Fever Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Swine Fever Vaccine key manufacturers include WINSUN, CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva, ChengDu Tecbond, Veterinary and Ringpu Biology, etc. WINSUN, CAHIC, Merial are top 3 players and held % sales share in total in 2022.
Swine Fever Vaccine can be divided into Tissue Culture Origin and Cell Line Origin, etc. Tissue Culture Origin is the mainstream product in the market, accounting for % sales share globally in 2022.
Swine Fever Vaccine is widely used in various fields, such as Government Tender and Market Sales, etc. Government Tender provides greatest supports to the Swine Fever Vaccine industry development. In 2022, global % sales of Swine Fever Vaccine went into Government Tender filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Swine Fever Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


WINSUN
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Segment by Type
Tissue Culture Origin
Cell Line Origin

Segment by Application


Government Tender
Market Sales

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Swine Fever Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Swine Fever Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Swine Fever Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Swine Fever Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Swine Fever Vaccine introduction, etc. Swine Fever Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Swine Fever Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Swine Fever Vaccine Market Overview
1.1 Swine Fever Vaccine Product Overview
1.2 Swine Fever Vaccine Market Segment by Type
1.2.1 Tissue Culture Origin
1.2.2 Cell Line Origin
1.3 Global Swine Fever Vaccine Market Size by Type
1.3.1 Global Swine Fever Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Swine Fever Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Swine Fever Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Swine Fever Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Swine Fever Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Swine Fever Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Swine Fever Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Swine Fever Vaccine Sales Breakdown by Type (2024-2024)
2 Global Swine Fever Vaccine Market Competition by Company
2.1 Global Top Players by Swine Fever Vaccine Sales (2024-2024)
2.2 Global Top Players by Swine Fever Vaccine Revenue (2024-2024)
2.3 Global Top Players by Swine Fever Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Swine Fever Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Swine Fever Vaccine Market Competitive Situation and Trends
2.5.1 Swine Fever Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Swine Fever Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Fever Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Swine Fever Vaccine Market
2.8 Key Manufacturers Swine Fever Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Swine Fever Vaccine Status and Outlook by Region
3.1 Global Swine Fever Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Swine Fever Vaccine Historic Market Size by Region
3.2.1 Global Swine Fever Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Swine Fever Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Swine Fever Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Swine Fever Vaccine Forecasted Market Size by Region
3.3.1 Global Swine Fever Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Swine Fever Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Swine Fever Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Swine Fever Vaccine by Application
4.1 Swine Fever Vaccine Market Segment by Application
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Swine Fever Vaccine Market Size by Application
4.2.1 Global Swine Fever Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Swine Fever Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Swine Fever Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Swine Fever Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Swine Fever Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Swine Fever Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Swine Fever Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Swine Fever Vaccine Sales Breakdown by Application (2024-2024)
5 North America Swine Fever Vaccine by Country
5.1 North America Swine Fever Vaccine Historic Market Size by Country
5.1.1 North America Swine Fever Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Swine Fever Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Swine Fever Vaccine Sales in Value by Country (2024-2024)
5.2 North America Swine Fever Vaccine Forecasted Market Size by Country
5.2.1 North America Swine Fever Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Swine Fever Vaccine Sales in Value by Country (2024-2034)
6 Europe Swine Fever Vaccine by Country
6.1 Europe Swine Fever Vaccine Historic Market Size by Country
6.1.1 Europe Swine Fever Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Swine Fever Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Swine Fever Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Swine Fever Vaccine Forecasted Market Size by Country
6.2.1 Europe Swine Fever Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Swine Fever Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Swine Fever Vaccine by Region
7.1 Asia-Pacific Swine Fever Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Swine Fever Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Swine Fever Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Swine Fever Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Swine Fever Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Swine Fever Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Swine Fever Vaccine Sales in Value by Region (2024-2034)
8 Latin America Swine Fever Vaccine by Country
8.1 Latin America Swine Fever Vaccine Historic Market Size by Country
8.1.1 Latin America Swine Fever Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Swine Fever Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Swine Fever Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Swine Fever Vaccine Forecasted Market Size by Country
8.2.1 Latin America Swine Fever Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Swine Fever Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Swine Fever Vaccine by Country
9.1 Middle East and Africa Swine Fever Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Swine Fever Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Swine Fever Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Swine Fever Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Swine Fever Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Swine Fever Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Swine Fever Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 WINSUN
10.1.1 WINSUN Company Information
10.1.2 WINSUN Introduction and Business Overview
10.1.3 WINSUN Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 WINSUN Swine Fever Vaccine Products Offered
10.1.5 WINSUN Recent Development
10.2 CAHIC
10.2.1 CAHIC Company Information
10.2.2 CAHIC Introduction and Business Overview
10.2.3 CAHIC Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 CAHIC Swine Fever Vaccine Products Offered
10.2.5 CAHIC Recent Development
10.3 Merial
10.3.1 Merial Company Information
10.3.2 Merial Introduction and Business Overview
10.3.3 Merial Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Merial Swine Fever Vaccine Products Offered
10.3.5 Merial Recent Development
10.4 MSD Animal Health
10.4.1 MSD Animal Health Company Information
10.4.2 MSD Animal Health Introduction and Business Overview
10.4.3 MSD Animal Health Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 MSD Animal Health Swine Fever Vaccine Products Offered
10.4.5 MSD Animal Health Recent Development
10.5 Chopper Biology
10.5.1 Chopper Biology Company Information
10.5.2 Chopper Biology Introduction and Business Overview
10.5.3 Chopper Biology Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Chopper Biology Swine Fever Vaccine Products Offered
10.5.5 Chopper Biology Recent Development
10.6 Ceva
10.6.1 Ceva Company Information
10.6.2 Ceva Introduction and Business Overview
10.6.3 Ceva Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Ceva Swine Fever Vaccine Products Offered
10.6.5 Ceva Recent Development
10.7 ChengDu Tecbond
10.7.1 ChengDu Tecbond Company Information
10.7.2 ChengDu Tecbond Introduction and Business Overview
10.7.3 ChengDu Tecbond Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 ChengDu Tecbond Swine Fever Vaccine Products Offered
10.7.5 ChengDu Tecbond Recent Development
10.8 Veterinary
10.8.1 Veterinary Company Information
10.8.2 Veterinary Introduction and Business Overview
10.8.3 Veterinary Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Veterinary Swine Fever Vaccine Products Offered
10.8.5 Veterinary Recent Development
10.9 Ringpu Biology
10.9.1 Ringpu Biology Company Information
10.9.2 Ringpu Biology Introduction and Business Overview
10.9.3 Ringpu Biology Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Ringpu Biology Swine Fever Vaccine Products Offered
10.9.5 Ringpu Biology Recent Development
10.10 Qilu Animal
10.10.1 Qilu Animal Company Information
10.10.2 Qilu Animal Introduction and Business Overview
10.10.3 Qilu Animal Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Qilu Animal Swine Fever Vaccine Products Offered
10.10.5 Qilu Animal Recent Development
10.11 DHN
10.11.1 DHN Company Information
10.11.2 DHN Introduction and Business Overview
10.11.3 DHN Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.11.4 DHN Swine Fever Vaccine Products Offered
10.11.5 DHN Recent Development
10.12 CAVAC
10.12.1 CAVAC Company Information
10.12.2 CAVAC Introduction and Business Overview
10.12.3 CAVAC Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.12.4 CAVAC Swine Fever Vaccine Products Offered
10.12.5 CAVAC Recent Development
10.13 Komipharm
10.13.1 Komipharm Company Information
10.13.2 Komipharm Introduction and Business Overview
10.13.3 Komipharm Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Komipharm Swine Fever Vaccine Products Offered
10.13.5 Komipharm Recent Development
10.14 Agrovet
10.14.1 Agrovet Company Information
10.14.2 Agrovet Introduction and Business Overview
10.14.3 Agrovet Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Agrovet Swine Fever Vaccine Products Offered
10.14.5 Agrovet Recent Development
10.15 Bioveta
10.15.1 Bioveta Company Information
10.15.2 Bioveta Introduction and Business Overview
10.15.3 Bioveta Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Bioveta Swine Fever Vaccine Products Offered
10.15.5 Bioveta Recent Development
10.16 Jinyu Bio-Technology
10.16.1 Jinyu Bio-Technology Company Information
10.16.2 Jinyu Bio-Technology Introduction and Business Overview
10.16.3 Jinyu Bio-Technology Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Jinyu Bio-Technology Swine Fever Vaccine Products Offered
10.16.5 Jinyu Bio-Technology Recent Development
10.17 Institutul Pasteur
10.17.1 Institutul Pasteur Company Information
10.17.2 Institutul Pasteur Introduction and Business Overview
10.17.3 Institutul Pasteur Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Institutul Pasteur Swine Fever Vaccine Products Offered
10.17.5 Institutul Pasteur Recent Development
10.18 MVP
10.18.1 MVP Company Information
10.18.2 MVP Introduction and Business Overview
10.18.3 MVP Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.18.4 MVP Swine Fever Vaccine Products Offered
10.18.5 MVP Recent Development
10.19 Tecon
10.19.1 Tecon Company Information
10.19.2 Tecon Introduction and Business Overview
10.19.3 Tecon Swine Fever Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Tecon Swine Fever Vaccine Products Offered
10.19.5 Tecon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Swine Fever Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Swine Fever Vaccine Industrial Chain Analysis
11.4 Swine Fever Vaccine Market Dynamics
11.4.1 Swine Fever Vaccine Industry Trends
11.4.2 Swine Fever Vaccine Market Drivers
11.4.3 Swine Fever Vaccine Market Challenges
11.4.4 Swine Fever Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Swine Fever Vaccine Distributors
12.3 Swine Fever Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tissue Culture Origin
Table 2. Major Company of Cell Line Origin
Table 3. Global Swine Fever Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Swine Fever Vaccine Sales by Type (2024-2024) & (K Doses)
Table 5. Global Swine Fever Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Swine Fever Vaccine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Swine Fever Vaccine Market Share in Value by Type (2024-2024)
Table 8. Global Swine Fever Vaccine Price by Type (2024-2024) & (USD/dose)
Table 9. Global Swine Fever Vaccine Sales by Type (2024-2034) & (K Doses)
Table 10. Global Swine Fever Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Swine Fever Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Swine Fever Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Swine Fever Vaccine Price by Type (2024-2034) & (USD/dose)
Table 14. North America Swine Fever Vaccine Sales by Type (2024-2024) & (K Doses)
Table 15. North America Swine Fever Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Swine Fever Vaccine Sales (K Doses) by Type (2024-2024)
Table 17. Europe Swine Fever Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Swine Fever Vaccine Sales (K Doses) by Type (2024-2024)
Table 19. Asia-Pacific Swine Fever Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Swine Fever Vaccine Sales (K Doses) by Type (2024-2024)
Table 21. Latin America Swine Fever Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Swine Fever Vaccine Sales (K Doses) by Type (2024-2024)
Table 23. Middle East and Africa Swine Fever Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Swine Fever Vaccine Sales by Company (2024-2024) & (K Doses)
Table 25. Global Swine Fever Vaccine Sales Share by Company (2024-2024)
Table 26. Global Swine Fever Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Swine Fever Vaccine Revenue Share by Company (2024-2024)
Table 28. Global Market Swine Fever Vaccine Price by Company (2024-2024) & (USD/dose)
Table 29. Global Swine Fever Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Swine Fever Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Swine Fever Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Swine Fever Vaccine Market
Table 33. Key Manufacturers Swine Fever Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Swine Fever Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Swine Fever Vaccine Sales by Region (2024-2024) & (K Doses)
Table 37. Global Swine Fever Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Swine Fever Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Swine Fever Vaccine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Swine Fever Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2024-2024)
Table 41. Global Swine Fever Vaccine Sales by Region (2024-2034) & (K Doses)
Table 42. Global Swine Fever Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Swine Fever Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Swine Fever Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Swine Fever Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2024-2034)
Table 46. Global Swine Fever Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Swine Fever Vaccine Sales by Application (2024-2024) & (K Doses)
Table 48. Global Swine Fever Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Swine Fever Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Swine Fever Vaccine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Swine Fever Vaccine Price by Application (2024-2024) & (USD/dose)
Table 52. Global Swine Fever Vaccine Sales by Application (2024-2034) & (K Doses)
Table 53. Global Swine Fever Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Swine Fever Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Swine Fever Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Swine Fever Vaccine Price by Application (2024-2034) & (USD/dose)
Table 57. North America Swine Fever Vaccine Sales by Application (2024-2024) (K Doses)
Table 58. North America Swine Fever Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Swine Fever Vaccine Sales by Application (2024-2024) (K Doses)
Table 60. Europe Swine Fever Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Swine Fever Vaccine Sales by Application (2024-2024) (K Doses)
Table 62. Asia-Pacific Swine Fever Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Swine Fever Vaccine Sales by Application (2024-2024) (K Doses)
Table 64. Latin America Swine Fever Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Swine Fever Vaccine Sales by Application (2024-2024) (K Doses)
Table 66. Middle East and Africa Swine Fever Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Swine Fever Vaccine Sales by Country (2024-2024) & (K Doses)
Table 68. North America Swine Fever Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Swine Fever Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Swine Fever Vaccine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Swine Fever Vaccine Sales by Country (2024-2034) & (K Doses)
Table 72. North America Swine Fever Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Swine Fever Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Swine Fever Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Swine Fever Vaccine Sales by Country (2024-2024) & (K Doses)
Table 76. Europe Swine Fever Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Swine Fever Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Swine Fever Vaccine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Swine Fever Vaccine Sales by Country (2024-2034) & (K Doses)
Table 80. Europe Swine Fever Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Swine Fever Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Swine Fever Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Swine Fever Vaccine Sales by Region (2024-2024) & (K Doses)
Table 84. Asia-Pacific Swine Fever Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Swine Fever Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Swine Fever Vaccine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Swine Fever Vaccine Sales by Region (2024-2034) & (K Doses)
Table 88. Asia-Pacific Swine Fever Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Swine Fever Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Swine Fever Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Swine Fever Vaccine Sales by Country (2024-2024) & (K Doses)
Table 92. Latin America Swine Fever Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Swine Fever Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Swine Fever Vaccine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Swine Fever Vaccine Sales by Country (2024-2034) & (K Doses)
Table 96. Latin America Swine Fever Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Swine Fever Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Swine Fever Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Swine Fever Vaccine Sales by Country (2024-2024) & (K Doses)
Table 100. Middle East and Africa Swine Fever Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Swine Fever Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Swine Fever Vaccine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Swine Fever Vaccine Sales by Country (2024-2034) & (K Doses)
Table 104. Middle East and Africa Swine Fever Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Swine Fever Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Swine Fever Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. WINSUN Company Information
Table 108. WINSUN Introduction and Business Overview
Table 109. WINSUN Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 110. WINSUN Swine Fever Vaccine Product
Table 111. WINSUN Recent Development
Table 112. CAHIC Company Information
Table 113. CAHIC Introduction and Business Overview
Table 114. CAHIC Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 115. CAHIC Swine Fever Vaccine Product
Table 116. CAHIC Recent Development
Table 117. Merial Company Information
Table 118. Merial Introduction and Business Overview
Table 119. Merial Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 120. Merial Swine Fever Vaccine Product
Table 121. Merial Recent Development
Table 122. MSD Animal Health Company Information
Table 123. MSD Animal Health Introduction and Business Overview
Table 124. MSD Animal Health Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 125. MSD Animal Health Swine Fever Vaccine Product
Table 126. MSD Animal Health Recent Development
Table 127. Chopper Biology Company Information
Table 128. Chopper Biology Introduction and Business Overview
Table 129. Chopper Biology Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 130. Chopper Biology Swine Fever Vaccine Product
Table 131. Chopper Biology Recent Development
Table 132. Ceva Company Information
Table 133. Ceva Introduction and Business Overview
Table 134. Ceva Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 135. Ceva Swine Fever Vaccine Product
Table 136. Ceva Recent Development
Table 137. ChengDu Tecbond Company Information
Table 138. ChengDu Tecbond Introduction and Business Overview
Table 139. ChengDu Tecbond Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 140. ChengDu Tecbond Swine Fever Vaccine Product
Table 141. ChengDu Tecbond Recent Development
Table 142. Veterinary Company Information
Table 143. Veterinary Introduction and Business Overview
Table 144. Veterinary Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 145. Veterinary Swine Fever Vaccine Product
Table 146. Veterinary Recent Development
Table 147. Ringpu Biology Company Information
Table 148. Ringpu Biology Introduction and Business Overview
Table 149. Ringpu Biology Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 150. Ringpu Biology Swine Fever Vaccine Product
Table 151. Ringpu Biology Recent Development
Table 152. Qilu Animal Company Information
Table 153. Qilu Animal Introduction and Business Overview
Table 154. Qilu Animal Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 155. Qilu Animal Swine Fever Vaccine Product
Table 156. Qilu Animal Recent Development
Table 157. DHN Company Information
Table 158. DHN Introduction and Business Overview
Table 159. DHN Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 160. DHN Swine Fever Vaccine Product
Table 161. DHN Recent Development
Table 162. CAVAC Company Information
Table 163. CAVAC Introduction and Business Overview
Table 164. CAVAC Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 165. CAVAC Swine Fever Vaccine Product
Table 166. CAVAC Recent Development
Table 167. Komipharm Company Information
Table 168. Komipharm Introduction and Business Overview
Table 169. Komipharm Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 170. Komipharm Swine Fever Vaccine Product
Table 171. Komipharm Recent Development
Table 172. Agrovet Company Information
Table 173. Agrovet Introduction and Business Overview
Table 174. Agrovet Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 175. Agrovet Swine Fever Vaccine Product
Table 176. Agrovet Recent Development
Table 177. Bioveta Company Information
Table 178. Bioveta Introduction and Business Overview
Table 179. Bioveta Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 180. Bioveta Swine Fever Vaccine Product
Table 181. Bioveta Recent Development
Table 182. Jinyu Bio-Technology Company Information
Table 183. Jinyu Bio-Technology Introduction and Business Overview
Table 184. Jinyu Bio-Technology Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 185. Jinyu Bio-Technology Swine Fever Vaccine Product
Table 186. Jinyu Bio-Technology Recent Development
Table 187. Institutul Pasteur Company Information
Table 188. Institutul Pasteur Introduction and Business Overview
Table 189. Institutul Pasteur Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 190. Institutul Pasteur Swine Fever Vaccine Product
Table 191. Institutul Pasteur Recent Development
Table 192. MVP Company Information
Table 193. MVP Introduction and Business Overview
Table 194. MVP Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 195. MVP Swine Fever Vaccine Product
Table 196. MVP Recent Development
Table 197. Tecon Company Information
Table 198. Tecon Introduction and Business Overview
Table 199. Tecon Swine Fever Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2024-2024)
Table 200. Tecon Swine Fever Vaccine Product
Table 201. Tecon Recent Development
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Swine Fever Vaccine Market Trends
Table 205. Swine Fever Vaccine Market Drivers
Table 206. Swine Fever Vaccine Market Challenges
Table 207. Swine Fever Vaccine Market Restraints
Table 208. Swine Fever Vaccine Distributors List
Table 209. Swine Fever Vaccine Downstream Customers
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Swine Fever Vaccine Product Picture
Figure 2. Global Swine Fever Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Swine Fever Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Swine Fever Vaccine Sales Status and Outlook (2024-2034) & (K Doses)
Figure 5. Product Picture of Tissue Culture Origin
Figure 6. Global Tissue Culture Origin Sales YoY Growth (2024-2034) & (K Doses)
Figure 7. Product Picture of Cell Line Origin
Figure 8. Global Cell Line Origin Sales YoY Growth (2024-2034) & (K Doses)
Figure 9. Global Swine Fever Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Swine Fever Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Swine Fever Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Swine Fever Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Swine Fever Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Swine Fever Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Swine Fever Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Swine Fever Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Swine Fever Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Swine Fever Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Swine Fever Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Swine Fever Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Fever Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Swine Fever Vaccine Revenue in 2022
Figure 23. Swine Fever Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Government Tender
Figure 25. Global Government Tender Sales YoY Growth (2024-2034) & (K Doses)
Figure 26. Product Picture of Market Sales
Figure 27. Global Market Sales Sales YoY Growth (2024-2034) & (K Doses)
Figure 28. Global Swine Fever Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Swine Fever Vaccine Sales Market Share by Application in 2022 & 2034
Figure 30. North America Swine Fever Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Swine Fever Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Swine Fever Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Swine Fever Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Swine Fever Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Swine Fever Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Swine Fever Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Swine Fever Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Swine Fever Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Swine Fever Vaccine Manufacturing Cost Structure
Figure 41. Swine Fever Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed